Award recordCONTRACT

BIOLOGICS, INC.

PIID 36C25621P1315· VHA· 256-NETWORK CONTRACT OFFICE 16 (36C256)· 6505 · DRUGS AND BIOLOGICALS· FY2021· $56,607 net obligations· UEI GVRYEDLFU6J3· NC

Description

ADD CAPRELSA 100MG

Base award description: CAPRELSA 300MG

First action · last action
2021-07-27 · 2023-03-26
Transactions
3
First transaction's obligation
$123,304
Base + all options value (sum of deltas)
$56,607
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$123,304$0Base award · 2021-07-27 · this action $123,304 · running total $123,304Modification P00001 · 2021-11-19 · this action -$51,254 · running total $72,050Modification P00002 · 2023-03-26 · this action -$15,444 · running total $56,607
  • Base2021-07-27+$123,304= $123,304
  • Mod P000012021-11-19-$51,254= $72,050
  • Mod P000022023-03-26-$15,444= $56,607
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2021-07-27+$123,304$123,304CAPRELSA 300MG
Mod P00001· ADDITIONAL WORK (NEW AGREEMENT, JUSTIFICATION REQUIRED)2021-11-19−$51,254$72,050ADD CAPRELSA 100MG
Mod P00002· FUNDING ONLY ACTION2023-03-26−$15,444$56,607ADD CAPRELSA 100MG

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI GVRYEDLFU6J3)

AwardOffice · PSC / listingNet obligationsFY
36C26126P0068261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$29,628FY2026
36C26125P1616261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$18,697FY2025
36C26125P1544261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$77,456FY2025
36C25925P1069NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$10,035FY2025
36C26223P0842262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36C24222P0293242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$10,296FY2022

Other recipients under 6505 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25626N0555CARDINAL HEALTH 414, LLC256-NETWORK CONTRACT OFFICE 16 (36C256)$654,692FY2026
36C25626P0618HANGER PROSTHETICS & ORTHOTICS INC256-NETWORK CONTRACT OFFICE 16 (36C256)$15,119FY2026
36C25626N0492BAYER HEALTHCARE PHARMACEUTICALS INC256-NETWORK CONTRACT OFFICE 16 (36C256)$386,860FY2026
36C25626N0469CARDINAL HEALTH 414, LLC256-NETWORK CONTRACT OFFICE 16 (36C256)$396,000FY2026
36C25626N0461CARDINAL HEALTH 414, LLC256-NETWORK CONTRACT OFFICE 16 (36C256)$271,226FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25621P1315_3600_-NONE-_-NONE- · retrieved 2026-09-26.